Biotech Group Acquisition Corporation (BGAC)

Biotech Group Acquisition will go public soon, but the exact IPO date is still unknown.
Stock Price: $10.00
Confirmed IPO price

Company Description

Biotech Group Acquisition Corporation is a newly organized blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

We intend to leverage the knowledge, expertise, capabilities and deep industry relationships of our management team and board of directors to focus on biotechnology companies with the potential to capitalize on the growing biotechnology sector in North America and the Asia-Pacific region (excluding China, Hong Kong and Macau).

Biotech Group Acquisition Corporation
Country United States
Founded 2022
Industry Blank Check / SPAC
CEO Yiru (Melody) Shi

Contact Details

2400 Barranca Pkwy, Suite 300
Irvine, CA 92606
United States
Phone (949) 468-7078

Stock Details

Ticker Symbol BGAC
Exchange NASDAQ
Reporting Currency US Dollars
IPO Price $10.00
CIK Code 1916902

Key Executives

Name Position
Yiru (Melody) Shi Chief Executive Officer and Chairwoman
Manu Ohri Chief Financial Officer and Director Nominee
Jingmin (Helen) Rogers Director Nominee
John Brugmann Director Nominee
Yi Wung Director Nominee

Latest SEC Filings

Date Type Title
May 25, 2022 S-1/A General form for registration of securities under the Securities Act of 1933
Apr 15, 2022 S-1 General form for registration of securities under the Securities Act of 1933
Mar 18, 2022 DRS Draft Registration Statement